Clinical Trial Update: Finistere Myeloma Observatory (OMYFIN)

View source ↗

Summary

The Finistere Myeloma Observatory (OMYFIN) trial for multiple myeloma has completed enrollment. The sponsor is University Hospital, Brest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University Hospital, Brest | Conditions: Multiple Myeloma | Status: COMPLETED